Deprescribing diabetes medications for older adults living with frailty
Treating to intensive glycemic targets (glycosylated hemoglobin [A1c] < 7%) increases the risk of adverse events and is unlikely to provide benefit given the reduced life expectancy of these patients.[1][1] Guidelines recommend individualized glycemic targets (i.e., A1c < 8.5%) in older adults with